A detailed history of Bdo Wealth Advisors, LLC transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, Bdo Wealth Advisors, LLC holds 4,700 shares of NYMX stock, worth $2,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,700
Previous 4,700 -0.0%
Holding current value
$2,209
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 25, 2022

BUY
$0.38 - $1.41 $1,786 - $6,627
4,700 New
4,700 $2,000
Q3 2021

Nov 09, 2021

SELL
$1.3 - $2.23 $6,110 - $10,481
-4,700 Closed
0 $0
Q2 2021

Sep 03, 2021

BUY
$1.46 - $2.48 $6,862 - $11,656
4,700 New
4,700 $7,000
Q3 2020

Nov 12, 2020

SELL
$2.3 - $3.66 $10,810 - $17,202
-4,700 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.69 - $3.88 $7,943 - $18,236
4,700 New
4,700 $11,000

Others Institutions Holding NYMX

About NYMOX PHARMACEUTICAL CORP


  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.